FDA Letter API

Solace Technologies, LLC d/b/a Solace Vapor

Letter data

Company
Solace Technologies, LLC d/b/a Solace Vapor
Recipient
Brendan McDermott | Solace Technologies, LLC d/b/a Solace Vapor | 2665 Park Center Drive Unit D | Simi Valley | , | CA | 93065 | United States | info@solacevapor.com | sales@solacevapor.com
Issue date
2021-04-09
Posted date
Not available
FDA office
Center for Tobacco Products
Subject
Not available
Product
Tobacco
CMS ID
583029
Reference number
RW1901096
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Solace Technologies, LLC d/b/a Solace Vapor MARCS-CMS 583029 — April 09, 2021 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA UPS and Electronic Mail Reference #: RW1901096 Product: Tobacco Recipient: Recipient Name Brendan McDermott Solace Technologies, LLC d/b/a Solace Vapor 2665 Park Center Drive Unit D Simi Valley , CA 93065 United States info@solacevapor.com sales@solacevapor.com Issuing Office: Center for Tobacco Products United States Dear Brendan McDermott: The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your responses dated June 19, 2019 and June 23, 2019, in response to our Warning Letter dated June 7, 2019. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding the Instagram account of Pandora Blue (https://www.instagram.com/pandora.blue), the Facebook account of Pandora Blue (https://www.facebook.com/pandorablueee), and the Twitter account of Pandora Blue (https://twitter.com/pandora_pblive), containing social media posts with labeling and/or advertising for e-liquid products on behalf of Solace Vapor, as well as the website https://solacevapor.com, the Instagram account of Solace Vapor (https://www.instagram.com/solacevapor), and the Facebook account of Solace Vapor(https://www.facebook.com/solacevapor). This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future. Sincerely, /S/ David Rice Branch Chief Division of Promotion, Advertising, and Labeling Office of Compliance and Enforcement Center for Tobacco Products VIA Electronic Mail Attn: Azim Chowdhury chowdhury@khlaw.com Content current as of: 04/22/2021 Regulated Product(s) Tobacco